Opportunity ID: 337297

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-360
Funding Opportunity Title: Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 10, 2022
Last Updated Date: Jan 04, 2023
Original Closing Date for Applications: Jan 07, 2025
Current Closing Date for Applications: Dec 23, 2022
Archive Date: Jan 22, 2023
Estimated Total Program Funding:
Award Ceiling: $325,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Small businesses
City or township governments
Native American tribal governments (Federally recognized)
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-360.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date
expired and re-issued as PAR-23-083 Jan 04, 2023
Jan 10, 2022

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-360
Funding Opportunity Title: Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 10, 2022
Last Updated Date: Jan 04, 2023
Original Closing Date for Applications: Jan 07, 2025
Current Closing Date for Applications: Dec 23, 2022
Archive Date: Jan 22, 2023
Estimated Total Program Funding:
Award Ceiling: $325,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Small businesses
City or township governments
Native American tribal governments (Federally recognized)
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-360.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-360
Funding Opportunity Title: Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 10, 2022
Last Updated Date: Jan 10, 2022
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 07, 2025
Archive Date: Feb 12, 2025
Estimated Total Program Funding:
Award Ceiling: $325,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
City or township governments
For profit organizations other than small businesses
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Small businesses
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-360.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Folder 337297 Full Announcement-PAR-21-360 -> PAR-21-360-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00271294 Feb 04, 2022 Jan 05, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278366 Nov 14, 2022 Jan 05, 2023 View

Package 1

Mandatory forms

337297 RR_SF424_5_0-5.0.pdf

337297 PHS398_CoverPageSupplement_5_0-5.0.pdf

337297 RR_OtherProjectInfo_1_4-1.4.pdf

337297 PerformanceSite_4_0-4.0.pdf

337297 RR_KeyPersonExpanded_4_0-4.0.pdf

337297 RR_Budget_3_0-3.0.pdf

337297 PHS398_ResearchPlan_4_0-4.0.pdf

337297 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

337297 RR_SubawardBudget30_3_0-3.0.pdf

337297 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

337297 RR_SF424_5_0-5.0.pdf

337297 PHS398_CoverPageSupplement_5_0-5.0.pdf

337297 RR_OtherProjectInfo_1_4-1.4.pdf

337297 PerformanceSite_4_0-4.0.pdf

337297 RR_KeyPersonExpanded_4_0-4.0.pdf

337297 RR_Budget_3_0-3.0.pdf

337297 PHS398_ResearchPlan_5_0-5.0.pdf

337297 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

337297 RR_SubawardBudget30_3_0-3.0.pdf

337297 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T09:35:29-05:00

Share This Post, Choose Your Platform!

About the Author: